Publications

The rise of RAS: how gradual oncogene activation shapes the OIS spectrum.

Authors: H Zhu, ASL Chan, M Narita

Research group: Narita Group

E-pub date: 1 Aug 2025

Journal name: Genes Dev

SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands.

Authors: JS Hardwick, S Dhir, A Kirchner, A Simeone, SM Flynn, JM Edgerton, R de Ces...

Research group: Balasubramanian Group

E-pub date: 31 Jul 2025

Journal name: Proceedings of the National Academy of Sciences

Biomarker risk stratification with capsule sponge in the surveillance of Barrett’s oesophagus: prospective evaluation of UK real-world implementation.

Authors: WK Tan, CS Ross-Innes, T Somerset, G Markert, F Markowetz, M O'Donovan, M d...

Research group: Markowetz Group

E-pub date: 19 Jul 2025

Journal name: Lancet

Non-canonical Hh signalling through Smoothened controls cytotoxic T cell migration in the tumor microenvironment

Authors: M de la Roche, C Kapeni

Research group: de la Roche Group

E-pub date: 11 Jul 2025

Journal name: Science Immunology

JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells

Authors: JW Deuel, A Makarovs, S Goosheh, G Winder, H Mohammed, JS Carroll, MS Chapm...

Research group: Carroll Group

E-pub date: 11 Jul 2025

Journal name:

Emerging in vivo tools for ILC2 research.

Authors: TYF Halim

Research group: Halim Group

E-pub date: 7 Jul 2025

Journal name: J Exp Med

Predicting resistance to chemotherapy using chromosomal instability signatures.

Authors: JS Thompson, L Madrid, B Hernando, CM Sauer, M Vias, M Escobar-Rey, W-K Leu...

Research group: Genomics, Markowetz Group, Brenton Group

E-pub date: 1 Jul 2025

Journal name: Nat Genet

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.

Authors: Z Fu, L Borho, SE Taylor, LE Kelemen, A DeFazio, PM Webb, M Köbel, NS Meag...

Research group: Brenton Group

E-pub date: 1 Jul 2025

Journal name: Gynecol Oncol

Filters

Research Groups

Core Facilities

Start date

End date

The rise of RAS: how gradual oncogene activation shapes the OIS spectrum.

SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands.

Biomarker risk stratification with capsule sponge in the surveillance of Barrett’s oesophagus: prospective evaluation of UK real-world implementation.

Non-canonical Hh signalling through Smoothened controls cytotoxic T cell migration in the tumor microenvironment

JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells

Emerging in vivo tools for ILC2 research.

Predicting resistance to chemotherapy using chromosomal instability signatures.

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

The rise of RAS: how gradual oncogene activation shapes the OIS spectrum.

SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strands.

Biomarker risk stratification with capsule sponge in the surveillance of Barrett’s oesophagus: prospective evaluation of UK real-world implementation.

Non-canonical Hh signalling through Smoothened controls cytotoxic T cell migration in the tumor microenvironment

JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells

Emerging in vivo tools for ILC2 research.

Predicting resistance to chemotherapy using chromosomal instability signatures.

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.